QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Tower Co. stock logo
AMT
American Tower
$171.30
+0.2%
$192.37
$154.58
$219.10
$79.89B0.672.43 million shs2.87 million shs
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$23.84
-0.7%
$26.41
$21.52
$33.08
$10.42B0.73964,516 shs749,283 shs
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Tower Co. stock logo
AMT
American Tower
-0.59%-4.28%-13.03%-16.12%-17.84%
Smith & Nephew plc stock logo
SNN
Smith & Nephew
+0.33%-2.10%-10.86%-14.79%-21.71%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
American Tower Co. stock logo
AMT
American Tower
4.926 of 5 stars
4.43.02.53.12.82.51.9
Smith & Nephew plc stock logo
SNN
Smith & Nephew
2.892 of 5 stars
0.05.02.50.03.30.01.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
American Tower Co. stock logo
AMT
American Tower
2.82
Moderate Buy$217.3626.89% Upside
Smith & Nephew plc stock logo
SNN
Smith & Nephew
2.40
HoldN/AN/A

Current Analyst Ratings

Latest SNN, ADR, and AMT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/15/2024
American Tower Co. stock logo
AMT
American Tower
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetEqual Weight ➝ Equal Weight$183.00 ➝ $196.00
4/8/2024
American Tower Co. stock logo
AMT
American Tower
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageNeutral$205.00
3/5/2024
American Tower Co. stock logo
AMT
American Tower
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$224.00 ➝ $234.00
2/28/2024
American Tower Co. stock logo
AMT
American Tower
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$235.00 ➝ $228.00
2/28/2024
American Tower Co. stock logo
AMT
American Tower
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$236.00 ➝ $230.00
1/24/2024
American Tower Co. stock logo
AMT
American Tower
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$229.00 ➝ $224.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
American Tower Co. stock logo
AMT
American Tower
$11.14B7.17$9.87 per share17.36$23.30 per share7.35
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$5.55B1.88$3.20 per share7.44$11.94 per share2.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
American Tower Co. stock logo
AMT
American Tower
$1.48B$3.1853.8716.601.3613.31%12.80%2.24%4/30/2024 (Confirmed)
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$263MN/A0.0011.461.29N/AN/AN/AN/A

Latest SNN, ADR, and AMT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/30/2024N/A
American Tower Co. stock logo
AMT
American Tower
$2.45N/A-$2.45N/AN/AN/A  
2/27/202412/31/2023
American Tower Co. stock logo
AMT
American Tower
$2.10$0.94-$1.16$0.18$2.74 billion$2.79 billion      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
American Tower Co. stock logo
AMT
American Tower
$6.483.78%+12.50%203.77%N/A
Smith & Nephew plc stock logo
SNN
Smith & Nephew
$0.903.78%N/AN/A1 Years

Latest SNN, ADR, and AMT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/4/2024
Smith & Nephew plc stock logo
SNN
Smith & Nephew
semi-annual$0.46202.8%4/1/20244/2/20245/22/2024
3/14/2024
American Tower Co. stock logo
AMT
American Tower
quarterly$1.623.3%4/11/20244/12/20244/26/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
American Tower Co. stock logo
AMT
American Tower
3.29
0.69
0.69
Smith & Nephew plc stock logo
SNN
Smith & Nephew
0.44
1.77
0.72

Ownership

Institutional Ownership

CompanyInstitutional Ownership
American Tower Co. stock logo
AMT
American Tower
92.69%
Smith & Nephew plc stock logo
SNN
Smith & Nephew
25.64%

Insider Ownership

CompanyInsider Ownership
American Tower Co. stock logo
AMT
American Tower
0.24%
Smith & Nephew plc stock logo
SNN
Smith & Nephew
1.00%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
American Tower Co. stock logo
AMT
American Tower
5,643466.35 million465.23 millionOptionable
Smith & Nephew plc stock logo
SNN
Smith & Nephew
18,452437.16 million432.79 millionOptionable

SNN, ADR, and AMT Headlines

SourceHeadline
Smith & Nephew UK Ltd: Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressings role in pressure injury preventionSmith & Nephew UK Ltd: Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing's role in pressure injury prevention
finanznachrichten.de - April 18 at 8:01 AM
Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury preventionSmith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention
markets.businessinsider.com - April 18 at 8:01 AM
Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury preventionSmith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention
finance.yahoo.com - April 18 at 8:01 AM
Raymond James & Associates Sells 511,426 Shares of Smith & Nephew plc (NYSE:SNN)Raymond James & Associates Sells 511,426 Shares of Smith & Nephew plc (NYSE:SNN)
marketbeat.com - April 18 at 4:08 AM
London & Capital Asset Management Ltd Purchases Shares of 38,622 Smith & Nephew plc (NYSE:SNN)London & Capital Asset Management Ltd Purchases Shares of 38,622 Smith & Nephew plc (NYSE:SNN)
marketbeat.com - April 15 at 11:28 AM
Short Interest in Smith & Nephew plc (NYSE:SNN) Declines By 17.5%Short Interest in Smith & Nephew plc (NYSE:SNN) Declines By 17.5%
americanbankingnews.com - April 15 at 6:30 AM
Smith & Nephew plc (NYSE:SNN) Sees Large Drop in Short InterestSmith & Nephew plc (NYSE:SNN) Sees Large Drop in Short Interest
marketbeat.com - April 13 at 7:42 AM
Smith+Nephew (SNN) Expands in Australia With New AllianceSmith+Nephew (SNN) Expands in Australia With New Alliance
zacks.com - April 11 at 10:16 AM
Smith+Nephew signs exclusive distribution agreement to provide unique NAVBIT SPRINT™ solution in AustraliaSmith+Nephew signs exclusive distribution agreement to provide unique NAVBIT SPRINT™ solution in Australia
globenewswire.com - April 8 at 6:00 PM
Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)
finance.yahoo.com - April 4 at 1:20 PM
Smith+Nephews PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)Smith+Nephew's PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)
globenewswire.com - April 4 at 11:13 AM
Smith+Nephew launches wound therapy system in USSmith+Nephew launches wound therapy system in US
msn.com - April 2 at 5:15 PM
Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic woundsSmith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds
globenewswire.com - April 1 at 8:00 AM
Smith & Nephew plc (NYSE:SNN) Given Consensus Rating of "Moderate Buy" by BrokeragesSmith & Nephew plc (NYSE:SNN) Given Consensus Rating of "Moderate Buy" by Brokerages
marketbeat.com - March 29 at 2:29 AM
European Equities Traded in the US as American Depositary Receipts Slightly Higher ThursdayEuropean Equities Traded in the US as American Depositary Receipts Slightly Higher Thursday
msn.com - March 28 at 12:11 PM
Smith & Nephew CFO designate John Rogers to start next weekSmith & Nephew CFO designate John Rogers to start next week
lse.co.uk - March 28 at 7:10 AM
Smith & Nephew: John Rogers Appointed CFOSmith & Nephew: John Rogers Appointed CFO
marketwatch.com - March 28 at 7:10 AM
Smith+Nephew: John Rogers To Join Board As Executive Director And CFO On 1 AprilSmith+Nephew: John Rogers To Join Board As Executive Director And CFO On 1 April
finanznachrichten.de - March 28 at 7:10 AM
Medical supplies firm Smith & Nephew teams up with mixed martial arts promoter the UFCMedical supplies firm Smith & Nephew teams up with mixed martial arts promoter the UFC
msn.com - March 25 at 7:16 PM
Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology PartnerSmith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner
globenewswire.com - March 25 at 8:00 AM
Scharf Investments LLC Has $81.30 Million Holdings in Smith & Nephew plc (NYSE:SNN)Scharf Investments LLC Has $81.30 Million Holdings in Smith & Nephew plc (NYSE:SNN)
marketbeat.com - March 21 at 8:54 PM
Smith & Nephew: Scepticism has been overplayed, says leading investment bankSmith & Nephew: Scepticism has been overplayed, says leading investment bank
proactiveinvestors.co.uk - March 11 at 10:25 AM
Smith & Nephew plc 2023 Q4 - Results - Earnings Call PresentationSmith & Nephew plc 2023 Q4 - Results - Earnings Call Presentation
seekingalpha.com - February 28 at 1:13 AM
Smith & Nephew reports Q4 resultsSmith & Nephew reports Q4 results
msn.com - February 27 at 8:46 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

American Tower logo

American Tower

NYSE:AMT
American Tower, one of the largest global REITs, is a leading independent owner, operator and developer of multitenant communications real estate with a portfolio of over 224,000 communications sites and a highly interconnected footprint of U.S. data center facilities.
Smith & Nephew logo

Smith & Nephew

NYSE:SNN
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprise instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high-definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg wounds, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. The company serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.